Regeneron Pharmaceuticals Inc Dividends
The next dividend date for Regeneron Pharmaceuticals Inc is August 18, 2026.
A dividend of $0.94 per share is scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Regeneron Pharmaceuticals Inc (REGN)
| 05/20/2026 | 04/29/2026 | 05/20/2026 | 06/04/2026 | $0.94 |
| 02/20/2026 | 01/30/2026 | 02/20/2026 | 03/05/2026 | $0.94 |
| 11/20/2025 | 10/28/2025 | 11/20/2025 | 12/05/2025 | $0.88 |
| 08/18/2025 | 08/01/2025 | 08/18/2025 | 09/03/2025 | $0.88 |
| 05/20/2025 | 04/29/2025 | 05/20/2025 | 06/06/2025 | $0.88 |
| 02/20/2025 | 02/04/2025 | 02/20/2025 | 03/20/2025 | $0.88 |
More About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of prematurity; Dupixent injection to treat atopic dermatitis and asthma; Libtayo injection for metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection to treat heterozygous familial hypercholesterolemia (HoFH); and Kevzara solution for rheumatoid arthritis. It has license and collaboration agreement with Bayer for the development and commercialization of EYLEA 8 mg and EYLEA; Alnylam Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for diseases by addressing therapeutic disease targets expressed in the eye and central nervous system; Intellia Therapeutics, Inc. to advance CRISPR/Cas9 gene-editing technology for in vivo therapeutic development for therapies focused on neurological and muscular diseases; Hansoh Pharmaceuticals Group Company Limited to acquire development and commercial rights for HS-20094, a dual GLP-1/GIP receptor; and Tessera Therapeutics, Inc. develops and commercializes TSRA-196, an investigational gene editing therapy for Alpha-1 antitrypsin deficiency. Additionally, the company has a strategic collaboration with Telix Pharmaceuticals Limited to develop and commercialize radiopharmaceutical therapies. It also has a strategic collaboration with CytomX Therapeutics, Inc. to create conditionally-activated bispecific cancer therapies. The company was incorporated in 1988 and is based in Tarrytown, New York.
Owning Regeneron Pharmaceuticals Inc Stock on the Dividend Date
If you own Regeneron Pharmaceuticals Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Regeneron Pharmaceuticals Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Regeneron Pharmaceuticals Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Regeneron Pharmaceuticals Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Regeneron Pharmaceuticals Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Owning Regeneron Pharmaceuticals Inc Options on the Dividend Date
Unlike the stock price, which will normally have an abrupt decrease by the amount of the dividend on the ex-dividend date, option prices typically do not reflect the same phenomenon.
The reason is that in the time leading up to the ex-dividend date, that projected drop in Regeneron Pharmaceuticals Inc stock price from the dividend is already baked into Regeneron Pharmaceuticals Inc option prices.
That means the prices of call options that overlap the Regeneron Pharmaceuticals Inc ex-dividend date typically go down in the period leading up to the ex-dividend date.
The prices of put options that overlap the Regeneron Pharmaceuticals Inc ex-dividend date typically go up in the period leading up to the ex-dividend date.
Owners of Regeneron Pharmaceuticals Inc call options do not receive the dividend, even if they own the options on the ex-dividend date. Owners of Regeneron Pharmaceuticals Inc put options are not responsible to pay the dividend, even if they own the options on the ex-dividend date.
Learning More Regeneron Pharmaceuticals Inc Dividends
You can contact us any time if you would like to ask questions about Regeneron Pharmaceuticals Inc dividends or anything else related to the stock market.